Crinetics Pharmaceuticals
CRNX
CRNX
181 hedge funds and large institutions have $2.54B invested in Crinetics Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 171 → 181 (+10)
3.15% more ownership
Funds ownership: 103.59% → 106.74% (+3.2%)
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Holders
181
Holding in Top 10
9
Calls
$22.4M
Puts
$11.9M
Top Buyers
| 1 | +$67.7M | |
| 2 | +$39.6M | |
| 3 | +$27.9M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$27.7M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$27.6M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$42.4M | |
| 3 | -$37.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.8M |
| 5 |
CC
Commodore Capital
New York
|
-$14.9M |